-
Signature
-
David Frydenlund as Attorney-in-Fact for Scott Bakken
-
Stock symbol
-
UUUU
-
Transactions as of
-
Jan 25, 2022
-
Transactions value $
-
$73,984
-
Form type
-
4
-
Date filed
-
1/26/2022, 10:03 AM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
UUUU |
Common Shares |
Award |
$74K |
+11.4K |
+14.04% |
$6.47 |
92.9K |
Jan 25, 2022 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
UUUU |
Stock Appreciation Rights ("SARs") |
Award |
$0 |
+20.8K |
+231.89% |
$0.00 |
29.8K |
Jan 25, 2022 |
Common Shares |
20.8K |
$6.47 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Remarks:
1. Reflects grant of 11,435 restricted stock units ("RSUs") which vest as follows: 50% on 01/27/2023; 25% on 01/27/2024; 25% on 01/27/2025. 2. Reflects grant of 20,833 stock appreciation rights ("SARs") which vest as follows: one-third of SARs automatically vest upon the volume weighted average price ("VWAP") of the Issuer's common stock on the NYSE American equaling or exceeding US$12.00 for any continuous 90-calendar-day period; another one-third of SARs automatically vest upon the VWAP of the Issuer's common stock on the NYSE American equaling or exceeding US$14.00 for any continuous 90-calendar-day period; and the final one-third vest upon the VWAP of the Issuer's common stock on the NYSE American equaling or exceeding US$16.00 for any continuous 90-calendar-day period. 3. Notwithstanding any vesting of any SARs, no SARs may be exercised until January 25, 2023, being the date that is one year after the date of grant.